MedPath

AMBISOME

AMBISOME

Approved
DIN Number

02241630

Drug Class

Human

Market Date

May 29, 2000

Company
HC

astellas pharma canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02241630
AIG Number0105864001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J02AA01 AMPHOTERICIN B
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:14.28
Health Canada Classification

ACTIVE INGREDIENTS (1)

AMPHOTERICIN BActive
Strength: 50 MG / VIAL
Monograph: AMPHOTERICIN B

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.